Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Press Releases

Fish's U.S. Supreme Court Mayo Clinic Case Named “2013 Impact Patent Case of the Year” by LMG Life Sciences

October 11, 2013

Press Releases

Fish's U.S. Supreme Court Mayo Clinic Case Named “2013 Impact Patent Case of the Year” by LMG Life Sciences

October 11, 2013

Back to News Listing

Boston, MA, October 11, 2013 – Fish & Richardson announced today that LMG Life Sciences has named its high profile U.S. Supreme Court win for Mayo Clinic in Mayo Collaborative Servs. v. Prometheus Labs one of two “2013 Impact Patent Cases of the Year.”  Fish won the unanimous 9-0 decision at the U.S. Supreme Court for long-time client Mayo Clinic in March 2012 after eight years of hard-fought patent litigation with Prometheus Laboratories.  The Court ruled in Mayo Clinic’s favor that Prometheus’ two broad drug monitoring patents were invalid and not patent eligible.

Prometheus’ patents had claimed a monopoly over naturally occurring correlations between metabolites of commonly used drugs and the toxicity or efficacy of those drugs, without specifying any concrete use of this correlation.  In effect, the patents would have restricted the right to simply observe a natural phenomenon, i.e., a physician who even thinks about how a patient’s body reacts when certain drugs and dosages are ingested could have infringed the patents.

“We are honored to see this case recognized for the significant implications it has had on not only intellectual property law, but on the ability of medical institutions like Mayo to provide optimal care to patients.  We are pleased that this decision is a positive one for medical research and patient care,” said Ann Cathcart Chaplin, Litigation Practice Group Leader at Fish.

Stay current with Fish Sign up for our Newsletter